L&C BIO Co.,LTD (KOSDAQ:290650)

Market Cap	1.45T +15.8%
Revenue (ttm)	116.30B +53.2%
Net Income	-149.41B
EPS	-5,981.52
Shares Out	26.97M
PE Ratio	n/a
Forward PE	38.85
Dividend	50.00 (0.09%)
Ex-Dividend Date	Dec 29, 2025

Volume	295,277
Open	55,600
Previous Close	56,300
Day's Range	53,000 - 56,600
52-Week Range	42,150 - 125,000
Beta	1.49
Analysts	Buy
Price Target	95,000.00 (+76.91%)
Est. Earnings	Nov 13, 2026

About L&C BIO Co.,LTD

L&C BIO Co.,LTD operates as a research and development company in tissue regeneration medicine. The company offers pharmaceuticals, human tissue, medical device, and cosmetics products. L&C BIO Co.,LTD was founded in 2011 and is headquartered in Seongnam-si, South Korea.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2011
• Employees: 172
• Stock Exchange: KOSDAQ
• Ticker Symbol: 290650

Analyst Summary

According to 3 analysts, the average rating for 290650 stock is "Buy." The 12-month stock price target is ₩95,000, which is an increase of 76.91% from the latest price.

Price Target

₩95,000

(76.91% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 2, 2026

Data Sources Report a data error